tirzepatide 20mg/ml 1ml vial 20mg Research Peptide Lilly releases Zepbound® (tirzepatide) single-dose

: , ( ) ,

Zepbound should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2)

The key variables in this analysis: what percentage of your total pharmacy spend is on generic drugs (typically 85-90% of prescription volume but only 20-30% of total drug spend), what percentage of those generics are classified as specialty by your current PBM (and thus dispensed through PBM-affiliated specialty pharmacies at inflated margins), and what is the spread between your current contracted price and Cost Plus acquisition cost for those drugs

Lilly has decided to launch Mounjaro as a private prescription so that Australian patients with type 2 diabetes can have immediate access to the HbA1c and weight reductions that Mounjaro may offer